Table 3 Evidence of infection at baseline based on positive serology with respect to diagnosis at 14–year follow-up
Infection | ReA n = 24 | RA n = 12 | UA n = 8 | CTD n = 7 | SpA + AS n = 6 | Other* n = 23 | All n = 80 |
|---|---|---|---|---|---|---|---|
ASO, n (%) | 3 (12.5) | 0 (0) | 1 (12.5) | 3 (42.9) | 1 (16.7) | 0 (0) | 8 (10) |
Chlamydia, n (%) | 10 (41.7) | 2 (16.7) | 0 (0) | 1 (14.3) | 0 (0) | 2 (8.7) | 15 (18.8) |
Yersinia, n (%) | 3 (12.5) | 1 (8.3) | 0 (0) | (0)0 | 1 (16.7) | 0 (0) | 5 (6.3) |
Salmonella, n (%) | 1 (4.2) | 0 (0) | 0 (0) | 0 (0)** | 1 (16.7) | 0 (0)** | 2 (2.5) |
Viral ab, n (%) | 1 (4.2) | 0 (0) | 0 (0) | 0 (0) | 0 (0)** | 4 (17.4) | 5 (6.3) |
Any positivity, n (%) | 17 (70.8) | 3 (25) | 1 (125) | 4 (57.1) | 2 (33.3) | 7 (30.4) | 34 (42.5) |